{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:21:31Z","timestamp":1779164491134,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903722"],"award-info":[{"award-number":["81903722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["YJSCX202203"],"award-info":[{"award-number":["YJSCX202203"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jchromb.2023.123765","type":"journal-article","created":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T21:14:14Z","timestamp":1684876454000},"page":"123765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Chiral pharmacokinetics of ibuprofen enantiomers in Chinese preterm neonates with patent ductus arteriosus using a validated UHPLC-MS\/MS method"],"prefix":"10.1016","volume":"1227","author":[{"given":"Dan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangjie","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisha","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changke","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoli","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yating","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanmian","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2023.123765_b0005","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-1209","article-title":"Patent ductus arteriosus of the preterm infant","volume":"146","author":"Hamrick","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.jchromb.2023.123765_b0010","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.1038\/s41598-021-89868-z","article-title":"Patent ductus arteriosus treatment trends and associated morbidities in neonates","volume":"11","author":"Park","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jchromb.2023.123765_b0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/archdischild-2020-321381","article-title":"Novel strategy to personalise use of ibuprofen for closure of patent ductus arteriosus in preterm neonates","volume":"107","author":"Samiee-Zafarghandy","year":"2022","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jchromb.2023.123765_b0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cpt.2616","article-title":"The effect of ibuprofen exposure and patient characteristics on the closure of the patent ductus arteriosus in preterm infants","volume":"112","author":"Engbers","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jchromb.2023.123765_b0025","series-title":"Pharmacometrics: The Science of Quantitative Pharmacology","first-page":"955","article-title":"Pharmacometrics in pharmacotherapy and drug development: Pediatric application","author":"Capparelli","year":"2006"},{"key":"10.1016\/j.jchromb.2023.123765_b0030","first-page":"485","article-title":"A Preterm physiologically based pharmacokinetic model","volume":"59","author":"Abduljalil","year":"2020","journal-title":"Part I: Physiological Parameters and Model Building, Clin Pharmacokinet"},{"key":"10.1016\/j.jchromb.2023.123765_b0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1081\/DMR-200047999","article-title":"Enantioselective pharmacokinetics of ibuprofen and involved mechanisms","volume":"37","author":"Hao","year":"2005","journal-title":"Drug Metab Rev"},{"issue":"Suppl 2","key":"10.1016\/j.jchromb.2023.123765_b0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2362.33.s2.6.x","article-title":"Clinical relevance of genetic polymorphisms in the human CYP2C9 gene","volume":"33","author":"Schwarz","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jchromb.2023.123765_b0045","first-page":"Cd003481","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants","volume":"9","author":"Ohlsson","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jchromb.2023.123765_b0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/cer-2020-0235","article-title":"Use of ibuprofen for the closure of patent ductus arteriosus in preterm infants: A systematic review of meta-analyses","volume":"10","author":"Al-Shaibi","year":"2021","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.jchromb.2023.123765_b0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000526210","article-title":"Oral ibuprofen is more effective than intravenous ibuprofen for closure of a patent ductus arteriosus: Can pharmacokinetic modeling help us to understand why?","volume":"120","author":"Smit","year":"2023","journal-title":"Neonatology"},{"key":"10.1016\/j.jchromb.2023.123765_b0060","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2125.2008.03118.x","article-title":"An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study","volume":"65","author":"Hirt","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jchromb.2023.123765_b0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00228-007-0273-9","article-title":"Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen","volume":"63","author":"Tornio","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jchromb.2023.123765_b0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phrs.2008.07.004","article-title":"Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers","volume":"58","author":"L\u00f3pez-Rodr\u00edguez","year":"2008","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jchromb.2023.123765_b0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/00498250210142994","article-title":"Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteers","volume":"32","author":"Tan","year":"2002","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jchromb.2023.123765_b0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF03191018","article-title":"Chiral separation of ibuprofen and chiral pharmacokinetics in healthy Chinese volunteers","volume":"33","author":"Zheng","year":"2008","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jchromb.2023.123765_b0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/chir.23308","article-title":"Ibuprofen enantiomers in premature neonates with patent ductus arteriosus: Preliminary data on an unexpected pharmacokinetic profile of S(+)-ibuprofen","volume":"33","author":"Padrini","year":"2021","journal-title":"Chirality"},{"key":"10.1016\/j.jchromb.2023.123765_b0090","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4155\/bio-2016-0013","article-title":"Determination of ibuprofen enantiomers in human plasma by HPLC-MS\/MS: Validation and application in neonates","volume":"8","author":"Chen","year":"2016","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2023.123765_b0095","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0378-4347(93)80126-O","article-title":"Stereospecific high-performance liquid chromatographic assay of ibuprofen: improved sensitivity and sample processing efficiency","volume":"619","author":"Lemko","year":"1993","journal-title":"J Chromatogr"},{"key":"10.1016\/j.jchromb.2023.123765_b0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02490926","article-title":"Enantiospecific analysis of ibuprofen by high performance liquid chromatography: Determination of free and total drug enantiomer concentrations in serum and urine","volume":"46","author":"Tan","year":"1997","journal-title":"Chromatographia"},{"key":"10.1016\/j.jchromb.2023.123765_b0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1099-0801(200006)14:4<219::AID-BMC969>3.0.CO;2-Z","article-title":"Determination of Ibuprofen in human plasma by high-performance liquid chromatography: Validation and application in pharmacokinetic study","volume":"14","author":"Canaparo","year":"2000","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.jchromb.2023.123765_b0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/chir.23148","article-title":"Effect of enantiomerism on the bioequivalence of a new ibuprofen 600-mg tablet formulation obtained by roller compaction","volume":"32","author":"Matji","year":"2020","journal-title":"Chirality"},{"key":"10.1016\/j.jchromb.2023.123765_b0115","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0731-7085(94)80033-2","article-title":"Development and validation of a liquid chromatographic method for the quantitation of ibuprofen enantiomers in human plasma","volume":"12","author":"Naidong","year":"1994","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jchromb.2023.123765_b0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jchromb.2003.07.010","article-title":"Stereospecific high-performance liquid chromatographic analysis of ibuprofen in rat serum","volume":"796","author":"Teng","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jchromb.2023.123765_b0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00228-010-0792-7","article-title":"Rationale and conditions for the requirement of chiral bioanalytical methods in bioequivalence studies","volume":"66","author":"Torrado","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jchromb.2023.123765_b0130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/dmd.116.073239","article-title":"Stereoselective pharmacokinetics and chiral inversion of ibuprofen in adjuvant-induced arthritic rats","volume":"45","author":"Ikuta","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jchromb.2023.123765_b0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0378-4347(00)00428-X","article-title":"Validation of a high-performance liquid chromatographic method for the determination of ibuprofen enantiomers in plasma of broiler chickens","volume":"749","author":"Vermeulen","year":"2000","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.jchromb.2023.123765_b0140","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.4155\/bio.12.275","article-title":"Determination of (S)-(+)- and (R)-(-)-ibuprofen enantiomers in human plasma after chiral precolumn derivatization by reversed-phase LC-ESI-MS\/MS","volume":"4","author":"Sharma","year":"2012","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2023.123765_b0145","first-page":"1587","article-title":"Determination of ibuprofen enantiomers in human plasma by LC-MS\/MS in pharmacokinetics study","volume":"52","author":"Huang","year":"2017","journal-title":"Yaoxue Xuebao"},{"key":"10.1016\/j.jchromb.2023.123765_b0150","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jchromb.2015.04.029","article-title":"Critical development by design of a rugged HPLC-MS\/MS method for direct determination of ibuprofen enantiomers in human plasma","volume":"992","author":"Nakov","year":"2015","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jchromb.2023.123765_b0155","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jchromb.2003.08.031","article-title":"Enantioselective determination of ibuprofen in plasma by high-performance liquid chromatography-electrospray mass spectrometry","volume":"796","author":"Bonato","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jchromb.2023.123765_b0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4236\/ajac.2010.12007","article-title":"A Validated enantioselective Assay for the determination of ibuprofen in human plasma using ultra performance liquid chromatography with tandem mass spectrometry (UPLC-MS\/MS)","volume":"1","author":"Szeitz","year":"2010","journal-title":"Am. J. Anal. Chem"},{"key":"10.1016\/j.jchromb.2023.123765_b0165","unstructured":"Food and Drug Administration, Guidance for Industry: Analytical Procedures and Methods Validation for Drugs and Biologics, 2018."},{"key":"10.1016\/j.jchromb.2023.123765_b0170","unstructured":"European Medicines Agency, Committee for Medicinal Products for Human Use, Guideline on Bioanalytical Method Validation, 2012."},{"key":"10.1016\/j.jchromb.2023.123765_b0175","unstructured":"National Medical Products Administration, Technical guidelines for clinical pharmacokinetics of chemical drugs, 2020."},{"key":"10.1016\/j.jchromb.2023.123765_b0180","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1177\/009127009203201209","article-title":"The effect of food or sucralfate on the bioavailability of S(+) and R(-) enantiomers of ibuprofen","volume":"32","author":"Levine","year":"1992","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jchromb.2023.123765_b0185","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.chroma.2016.12.064","article-title":"Separation of enantiomers of chiral weak acids with polysaccharide-based chiral columns and aqueous-organic mobile phases in high-performance liquid chromatography: Typical reversed-phase behavior?","volume":"1483","author":"Matarashvili","year":"2017","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.jchromb.2023.123765_b0190","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/jcph.532","article-title":"Reporting guidelines for population pharmacokinetic analyses","volume":"55","author":"Dykstra","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jchromb.2023.123765_b0195","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/jcph.307","article-title":"Plasma and cerebrospinal fluid concentrations of ibuprofen in pediatric patients and antipyretic effect: Pharmacokinetic-pharmacodynamic modeling analysis","volume":"54","author":"Har-Even","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jchromb.2023.123765_b0200","doi-asserted-by":"crossref","first-page":"F116","DOI":"10.1136\/adc.2011.215160","article-title":"Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants","volume":"97","author":"Barzilay","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.jchromb.2023.123765_b0205","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1177\/0091270008323752","article-title":"Population pharmacokinetic analysis of Ibuprofen enantiomers in preterm newborn infants","volume":"48","author":"Gregoire","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jchromb.2023.123765_b0210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s13318-022-00766-9","article-title":"Population pharmacokinetic modelling of acetaminophen and Ibuprofen: The influence of body composition, formulation and feeding in healthy adult volunteers","volume":"47","author":"Morse","year":"2022","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jchromb.2023.123765_b0215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00008571-199712000-00002","article-title":"Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: In-vivo\/in-vitro correlation and inducibility","volume":"7","author":"Treluyer","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jchromb.2023.123765_b0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1651-2227.1997.tb08892.x","article-title":"Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant","volume":"86","author":"Aranda","year":"1997","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jchromb.2023.123765_b0225","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbalip.2006.11.007","article-title":"Ontogeny of mRNA expression and activity of long-chain acyl-CoA synthetase (ACSL) isoforms in Mus musculus heart","volume":"1771","author":"de Jong","year":"2007","journal-title":"Biochim Biophys Acta"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223001757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223001757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:11:20Z","timestamp":1761606680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023223001757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":45,"alternative-id":["S1570023223001757"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123765","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chiral pharmacokinetics of ibuprofen enantiomers in Chinese preterm neonates with patent ductus arteriosus using a validated UHPLC-MS\/MS method","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123765"}}